epidem
respiratori
infect
due
new
coronaviru
emerg
end
china
pandem
associ
huge
number
death
mortal
rate
greatli
vari
countri
unexplain
high
rate
among
variou
caus
morbid
mortal
patient
frequenc
impact
coinfect
still
poorli
studi
particularli
patient
acut
respiratori
distress
syndrom
ard
grip
epidemiolog
point
must
underlin
iii
mortal
still
nt
know
exactli
fungal
coinfect
impact
mortal
awar
dramat
impact
influenzaipa
coinfect
mortal
reach
european
center
studi
schauwvliegh
mortal
rate
influenza
associ
ipa
without
ipa
besid
particular
pathophysiolog
may
also
account
unpreced
comorbid
ifi
first
high
aggress
featur
viru
lung
tissu
larg
bilater
alveolointerstiti
lesion
make
occurr
ifi
like
specif
primari
pulmonari
entri
airborn
rout
infect
ipa
pneumocystosi
pjp
mucormycosi
second
absolut
number
lymphocyt
cell
markedli
lower
sever
case
moder
case
associ
markedli
higher
level
tnfalpha
inflammatori
marker
numer
studi
implement
icu
patient
particularli
patient
ard
perform
diagnosi
ifi
usual
avail
complic
evalu
dynam
colon
risk
chronic
allerg
fungal
diseas
lower
extent
risk
invas
fungal
diseas
nonhospit
patient
chronic
respiratori
diseas
longterm
corticosteroid
therapi
may
part
risk
factor
balanc
underli
diseas
attribut
risk
factor
fungal
infect
difficult
appreci
larg
survey
registri
suffici
descript
patient
characterist
mandatori
propos
optim
diagnost
tool
ensur
correct
survey
particular
numer
laboratori
stop
manipul
risk
respiratori
sampl
direct
examin
galactomannan
determin
respiratori
sampl
besid
perform
blood
biomark
galactomannan
betadglucan
dna
detect
well
evalu
neutropen
patient
far
less
condit
franc
ifi
account
high
risk
mortal
patient
comorbid
depend
fungal
diseas
ia
notabl
diagnos
neutropen
patient
patient
chemotherapi
particularli
hematolog
malign
prolong
corticosteroid
therapi
biotherapi
hsct
allograft
solid
organ
transplant
chronic
respiratori
diseas
pcp
opportunist
infect
diagnos
lymphopen
patient
patient
coinfect
hiv
patient
suffer
hematolog
malign
solid
organ
transplant
chronic
respiratori
diseas
invas
mucormycosi
increasingli
report
thank
improv
diagnost
tool
suscept
patient
suffer
diabet
hematolog
malign
solid
organ
transplant
chronic
respiratori
diseas
superfici
injuri
burn
patient
local
traumat
use
local
literatur
data
global
burden
sever
fungal
infect
estim
approxim
case
franc
year
believ
microbiolog
diagnosi
promptli
adapt
current
unpreced
situat
accord
preliminari
data
avail
concern
occurr
ifi
patient
french
high
council
public
health
hscp
haut
conseil
de
la
publiqu
recommend
systemat
screen
fungal
pathogen
patient
admit
pneumonia
among
first
well
describ
french
patient
one
coinfect
aspergillu
flavu
context
vigil
essenti
consid
larg
panel
tool
must
propos
better
character
epidemiolog
ifi
strike
pandem
local
implement
diagnost
tool
optim
earli
diagnosi
order
allow
prompt
specif
antifung
treatment
optim
manag
patient
process
could
associ
effici
syndrom
molecular
approach
qpcr
aspergillu
pneumocysti
jiroveci
mucoral
associ
cultur
respiratori
sampl
case
posit
test
confirm
step
blood
biomark
implement
depend
posit
result
serum
galactomannan
andor
serum
betadglucan
andor
cryptococc
antigenemia
andor
blood
qpcr
aspergillu
mucoral
nation
multicentr
studi
aim
explor
risk
fungal
coinfect
joint
consortia
icu
mycolog
specialist
french
societi
medic
mycolog
sfmm
support
studi
contribut
nation
centr
nation
de
mycos
invas
et
antifongiqu
http
wwwpasteurfrfrsantepubliquecnrlescnrmycosesinvasivesantifongiqu
intern
registri
one
endors
european
confeder
medic
mycolog
ecmm
http
datacastoredccom
collect
goal
provid
origin
still
unknown
epidemiolog
data
focus
fungal
infect
better
evalu
incid
dynam
fungal
infect
cours
particularli
icu
stay
improv
diagnosi
propos
effici
syndrom
molecular
approach
fungal
respiratori
infect
ard
share
hospit
receiv
patient
optim
immedi
patient
manag
realtim
screen
order
introduc
earli
possibl
target
treatment
firstlin
treatment
aspergillosi
pneumocystosi
mucormycosi
far
differ
empir
treatment
avoid
much
possibl
depend
epidemiolog
data
obtain
prevent
strategi
antifung
chemoprophylaxi
environment
measur
could
envisag
aim
decreas
morbid
mortal
